Scientific Publications | Max Delbrück Center

977 Results:

Active Filter:

May 30, 2014 / Oncotarget

RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis

M. Dahlmann
A. Okhrimenko
P. Marcinkowski
M. Osterland
P. Herrmann
J. Smith
C.W. Heizmann
P.M. Schlag
U. Stein

September 19, 2019 / Rev Neurosci

Could electrical coupling contribute to the formation of cell assemblies?

R.D. Traub
M.A. Whittington
N. Maier
D. Schmitz
J.I. Nagy

January 01, 2004 / J Am Soc Nephrol

New aspects in the pathophysiology of preeclampsia

J.M. Davison
V. Homuth
A. Jeyabalan
K.P. Conrad
S.A. Karumanchi
S. Quaggin
R. Dechend
F.C. Luft

August 01, 1997 / Fibrinolysis

Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans

D.C. Gulba
M. Praus
R. Dechend
S. Hauck
M. Mahler
R. Zitvz
B. Baldus
W. Mueller
R. Dietz

May 23, 2000 / Circulation

AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor

R. Dechend
V. Homuth
G. Wallukat
J. Kreuzer
J.K. Park
J. Theuer
A. Juepner
D.C. Gulba
N. Mackman
H. Haller
F.C. Luft

July 01, 2000 / Am J Pathol

Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy

D.N. Mueller
E.M.A. Mervaala
R. Dechend
A. Fiebeler
J.K. Park
F. Schmidt
J. Theuer
V. Breu
N. Mackman
T. Luther
W. Schneider
D. Gulba
D. Ganten
H. Haller
F.C. Luft

September 01, 2002 / J Am Soc Nephrol

Postischemic acute renal failure is reduced by short-term statin treatment in a rat model

F. Gueler
S. Rong
J.K. Park
A. Fiebeler
J. Menne
M. Elger
D.N. Mueller
F. Hampich
R. Dechend
U. Kunter
F.C. Luft
H. Haller

November 10, 2002 / Int J Cancer

Mutation analysis and mRNA expression of trail-receptors in human breast cancer

S. Seitz
P. Wassmuth
J. Fischer
A. Nothnagel
B. Jandrig
P.M. Schlag
S. Scherneck

November 01, 2002 / Am J Pathol

Immunosuppressive treatment protects against angiotensin II-induced renal damage

D.N. Muller
E. Shagdarsuren
J.K. Park
R. Dechend
E. Mervaala
F. Hampich
A. Fiebeler
X. Ju
P. Finckenberg
J. Theuer
C. Viedt
J. Kreuzer
H. Heidecke
H. Haller
M. Zenke
F.C. Luft

December 01, 2002 / Hypertension

Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage

D.N. Muller
A. Mullally
R. Dechend
J.K. Park
A. Fiebeler
B. Pilz
B.M. Loeffler
D. Blum-Kaelin
S. Masur
H. Dehmlow
J.D. Aebi
H. Haller
F.C. Luft